课题基金 / 基金详情

Dissecting the molecular pathways of MDV oncoprotein Meq for understanding pathogenesis and aid vaccine development

Dissecting the molecular pathways of MDV oncoprotein Meq for understanding pathogenesis and aid vaccine development
剖析 MDV 癌蛋白 Meq 的分子通路,以了解发病机制并帮助疫苗开发
批准号:
BB/R007896/1
负责人:
YONGXIU YAO
金额:
$57.03万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --

项目摘要

项目成果

YONGXIU YAO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Infectious diseases result in direct and indirect losses at various steps of poultry farming and amongst them neoplastic disease caused by viruses is a major economic problem faced by the poultry industry worldwide. The oncogenic viruses causing neoplastic infection in chickens are herpesviruses comprising of Marek's disease virus (MDV) and retroviruses comprising of reticuloendotheliosis virus (REV) and avian leucosis virus (ALV). Marek's disease (MD) is a common disease of chickens involving paralysis and commonly death from the growth of highly malignant T lymphomas (cancers of white blood cells). MD is caused by a transmissible agent MDV. MDV is very contagious and is a major threat to the poultry industry worldwide. The estimated total loss from this disease worldwide is up to $2 billion. Presently, it is controlled by vaccination, and nearly 22 billion vaccine doses a year are used in an attempt to control the disease. Despite widespread vaccination, the threat from this disease is on increase due to continued evolution of MDV towards greater virulence, and more fundamental studies to understand the mechanisms by which this virus causes cancer is needed to develop more effective control programmes. Meq is the major oncoprotein in MDV induced tumorigenesis. Previously, we have identified Meq targetome in cancer cells. In this new grant proposal, to be carried out jointly between the Pirbright Institute and Roslin Institute, we want to extend these studies to obtain detailed information on the role of Meq and its targets in MDV induced oncogenesis using a number of advanced approaches including CRISPR/Cas9 genome editing we have recently established in the lab and rapid immunoprecipitation mass spectrometry of endogenous proteins (RIME) for Meq interactome identification. The study is very important to understand the mechanisms by which this virus induces cancer, some of which are valuable in understanding cancer in other species including humans. Finally, the findings from the project will be very valuable in developing new approaches for the control of cancers caused by oncogenic viruses.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3390/v12111249
发表时间: 2020-11-02
期刊: Viruses
影响因子: --
作者: [Jadhav A, Zhao L, Ledda A, Liu W, Ding C, Nair V, Ferretti L]
通讯作者: Ferretti L
DOI: 10.3390/vaccines10081358
发表时间: 2022-08-19
期刊: VACCINES
影响因子: 7.8
作者: [Apinda, Nisachon, Muenthaisong, Anucha, Chomjit, Paweena, Sangkakam, Kanokwan, Nambooppha, Boondarika, Rittipornlertrak, Amarin, Koonyosying, Pongpisid, Yao, Yongxiu, Nair, Venugopal, Sthitmatee, Nattawooti]
通讯作者: Sthitmatee, Nattawooti
DOI: 10.3390/v15071434
发表时间: 2023-06-25
期刊: Viruses
影响因子: --
作者: [Liu JL, Teng M, Zheng LP, Zhu FX, Ma SX, Li LY, Zhang ZH, Chai SJ, Yao Y, Luo J]
通讯作者: Luo J
DOI: 10.3390/v12111305
发表时间: 2020-11-14
期刊: Viruses
影响因子: --
作者: [Jadhav A, Zhao L, Liu W, Ding C, Nair V, Ramos-Onsins SE, Ferretti L]
通讯作者: Ferretti L
6
    Effects of co-infections on Marek's disease in poultry and development of novel recombinant Marek's disease virus vector vaccines
    • 批准号:
      BB/X017575/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $58.23万
    • 财政年份:
      2023
    • 负责人:
      YONGXIU YAO
    • 依托单位:
    Antigenic characterisation of infectious bursal disease virus to improve vaccination strategies and vaccine design
    • 批准号:
      BB/S014594/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $57.43万
    • 财政年份:
      2020
    • 负责人:
      YONGXIU YAO
    • 依托单位:
    UK-China partnership on Global Food Security: Combating avian tumor diseases for sustainable poultry production
    • 批准号:
      BB/R012865/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $49.57万
    • 财政年份:
      2018
    • 负责人:
      YONGXIU YAO
    • 依托单位:
    国内基金
    海外基金
    配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
    • 批准号:
      82371616
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      姚晨成
    • 依托单位:
    MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
    • 批准号:
      82370981
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      陈敏洁
    • 依托单位:
    PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
    • 批准号:
      82372073
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      张淼
    • 依托单位:
    GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
    • 批准号:
      82371652
    • 项目类别:
      面上项目
    • 资助金额:
      45.00万元
    • 批准年份:
      2023
    • 负责人:
      刘开江
    • 依托单位: